Real-world Demographics, Clinical Characteristics, Treatment Patterns and Clinical Outcomes for US Patients with Limited-Stage SCLC (LS-SCLC)

被引：0

作者：

Chiang, Anne C. ^{[1
]}

Salomonsen, Rachel ^{[2
]}

Wang, Alice ^{[2
]}

Holland, Rachel ^{[3
]}

Cai, Ling ^{[2
]}

Xiao, Yang ^{[2
]}

Sadow, Sam ^{[2
]}

Davey, Kieran ^{[3
]}

Iyengar, Puneeth ^{[4
]}

机构：

[1] Yale Univ, Sch Med, New Haven, CT USA

[2] AstraZeneca, Gaithersburg, MD USA

[3] AstraZeneca, Cambridge, England

[4] UT Southwestern Med Ctr, Dallas, TX USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 07期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PP01.90

引用

页码：E40 / E41

页数：2

共 50 条

[21] Brief Report: Real-World Eligibility for Clinical Trials in Patients With Extensive-Stage SCLC at a Tertiary Care Center
Dehar, Navdeep
Meem, Mahbuba
Aggarwal, Ishita
Hopman, Wilma
Gaudreau, Pierre-Olivier
Robinson, Andrew
Fung, Andrea S.
JTO CLINICAL AND RESEARCH REPORTS, 2024, 5 (07):
[22] Omitting elective nodal irradiation (ENI) during thoracic irradiation in limited-stage small cell lung cancer (LS-SCLC) - Patterns of failure from a phase II trial
Colaco, R.
Sheikh, H. Y.
Lorigan, P. C.
Blackhall, F. H.
Thatcher, N.
Taylor, P.
Faivre-Finn, C.
LUNG CANCER, 2010, 67 : S10 - S10
[23] Concurrent Chemoradiation ± Atezolizumab (atezo) in Limited-Stage Small Cell Lung Cancer (LS-SCLC): Results of NRG Oncology/Alliance LU005
Higgins, K.
Hu, C.
Ross, H. J.
Jabbour, S. K.
Kozono, D. E.
Owonikoko, T. K.
Dib, E. G.
Brownstein, J. M.
Kuzma, C.
Kotecha, R.
Onitilo, A. A.
Stinchcombe, T. E.
Wang, X.
Paulus, R.
Bradley, J. D.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S2 - S2
[24] CPT-11-CARBOPLATIN WITH EARLY CONCURRENT RADIOTHERAPY (CT/RT) IN LIMITED-STAGE SMALL CELL LUNG CANCER (LS-SCLC) PATIENTS (PTS). A PHASE II STUDY
Domine, M.
Leon, A.
Casado, V.
Rubio, G.
Martin, I.
Arlanzon, C.
Ortega, C.
Ramirez, N.
Fuentes, R.
Lobo, F.
ANNALS OF ONCOLOGY, 2008, 19 : 117 - 117
[25] Hypo- or Conventionally Fractionated Radiotherapy in Patients with Limited Stage Small Cell Lung Cancer (LS-SCLC): A Retrospective Analysis
Zhang, Jing
Fan, Min
Liu, Di
Shen, Yu Xin
Zhao, Kuai Le
Wu, Kai Liang
Zhao, Wei Xin
Li, Ling
Fu, Xiao Long
Zhu, Zheng Fei
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S500 - S500
[26] REAL-WORLD TREATMENT PATTERNS, HEALTHCARE RESOURCE UTILIZATION (HCRU) AND CLINICAL OUTCOMES OF PATIENTS WITH EXTENSIVE-STAGE SMALL-CELL LUNG CANCER (ES-SCLC) IN ALBERTA, CANADA
Suri, G.
Boyne, D. J.
Caveen, M.
Mak, D.
Takundwa, R.
Wani, R. J.
Cheung, W.
VALUE IN HEALTH, 2024, 27 (06) : S23 - S23
[27] Real-world treatment patterns and clinical outcomes in patients with stage III NSCLC in Korea: The KINDLE study
Lee, Jiyun
Ahn, Hee Kyung
Kim, Sang-We
Han, Ji-Youn
Lee, Sung Sook
Park, Hyung Soon
Lee, Hyun Woo
Kim, Joo-Hang
Cho, Eunhan
Huggenberger, Reto
Cho, Byoung Chul
CANCER MEDICINE, 2024, 13 (07):
[28] Real-world Clinical Characteristics, Treatment Patterns, and Exacerbations in US Patients With Asthma Newly Treated With Omalizumab
Ke, Xuehua
Kavati, Abhishek
Wertz, Debra
Huang, Qing
Wang, Liya
Willey, Vincent J.
Stephenson, Judith J.
Ortiz, Benjamin
Panettieri, Reynold A., Jr.
Corren, Jonathan
CLINICAL THERAPEUTICS, 2018, 40 (07) : 1140 - 1158
[29] Real-world demographics, clinical characteristics and treatment patterns in relapsing multiple sclerosis patients on disease-modifying therapy
Ziemssen, T.
Kurzeja, A.
Haas, J.
Alexander, J.
Driessen, M.
MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 547 - 548
[30] PHASE II STUDY COMPARING ACCELERATED TWICE DAILY AND ONCE DAILY THORACIC RADIOTHERAPY IN PATIENTS WITH LIMITED-STAGE SMALL CELL LUNG CANCER (LS-SCLC) TREATED CONCURRENTLY WITH CHEMOTHERAPY
Lee, C. E.
Lorigan, P.
Blackhall, F.
Taylor, P.
Ashcroft, L. F.
Thatcher, N.
Faivre-Finn, C.
JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S108 - S108

← 1 2 3 4 5 →